Dr. Peter Joseph Leary, MD, MS

Dr. Leary practices at UW Medical Center - Montlake in Seattle, Washington, part of University of Washington.

Dr. Leary's NPI, 1669675534, was assigned on June 7, 2007. Dr. Leary graduated from Johns Hopkins University School of Medicine in 2005. Dr. Leary holds Washington license 60085897.

Dr. Leary's primary practice is UW Medical Center - Montlake, at 1959 NE Pacific St Box 356151, Seattle, WA 98195 in King County. The practice phone is (206) 598-3300.

Dr. Leary's primary practice is UW Medical Center - Montlake in Seattle, Washington, part of University of Washington. The medical group on file is UW Physicians. Dmand AI also links Dr. Leary to 1 more hospital and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Leary practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Leary's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Leary is licensed in Washington.

CMS data shows 395 Medicare services from Dr. Leary across 7 procedure codes in 2024, for 120 Medicare patients. Medicare paid $28,338 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 120 Medicare patients who saw Dr. Leary in 2024. The largest group is 65 to 74, with 53 patients. 75% of them have heart failure, and 68% have high blood pressure. 19% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Leary's median patient age at 60, with 64% women.

In 2024, Dr. Leary wrote 1,514 Medicare Part D claims for 102 patients. 52% of them were for generic drugs. CMS names the drug for 1,406 of them, across 14 drugs with 11 or more claims each, at $11,609,873 in total drug cost. In 2023, CMS named 1,313 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Leary for performance year 2024, reported through an alternative payment model (APM). Dr. Leary accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Leary as offering telehealth.

Dmand AI links 81 papers to Dr. Leary, published from 2012 to 2025. 2022 was the busiest year, with 7. The most frequent topics are Hypertension, Pulmonary, Pulmonary Arterial Hypertension and Heart Failure. Dr. Leary has published most often in Ann Am Thorac Soc. Dr. Leary's most frequent co-authors are David D. Ralph, Ryan James Tedford, MD and Steven Mark Kawut, MD.

Dmand AI links Dr. Leary to 2 clinical trials. Conditions studied include Pulmonary Arterial Hypertension and Hypertension, Pulmonary. Open Payments lists research payments to Dr. Leary that name 1 trial.

CMS Open Payments shows 62 general payments to Dr. Leary from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 85% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $27,295. It also lists 3 research payments totaling $2,912 in 2016, naming 1 clinical trial.

Dr. Leary graduated from Johns Hopkins University School of Medicine in 2005.